Brief: Adverum Biotechnologies Files For Mixed Shelf Offering Of $200 Million
21/03/2024 22:08
March 21 (Reuters) - Adverum Biotechnologies Inc
ADVM.O :
* ADVERUM BIOTECHNOLOGIES INC: FILES FOR MIXED SHELF
OFFERING OF
$200 MILLION - SEC FILING
Source text for Eikon: ID:n0001193125-24-074000
Further company coverage: ADVM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Adverum Biotechnologies
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Adverum Reminds Stockholders To Tender Their Shares Into The Offer By Lilly
Brief: Adverum Biotechnologies Inc - Are-Nc Region No. 21 Llc Terminates Certain Lease Agreement With Adverum Biotechnologies - SEC Filing
Eli Lilly bets on eye care with buyout of gene therapy developer Adverum (updated)